Xconomy’s Digital Events →
Tim Mayleben is CEO of Aastrom Biosciences
Xconomy Insight · Special Report
Industry experts explain what it takes to launch a new biotech company
From Our Editors · Podcast
Becoming the Cell & Gene Therapy Hub
From Our Partners · Special Report
Advice for funding and future transformational opportunities